Article
Molecular Biomarkers of Anaplastic Thyroid Carcinoma.
Current molecular medicine - 1 Jan 2017
Bozorg-Ghalati F, Hedayati M
Abstract excerpt
Anaplastic thyroid carcinoma is the rarest but extremely aggressive thyroid cancer subtype. This neoplasia is composed of undifferentiated tumor cells with poor prognosis and resistant to common thyroid cancer therapy. Early stage identification of this cancer for prompt treatment is very vital. Presently, cytological evaluation of fine needle aspiration biopsy (FNAB) which is known as invasive recognition assay,...
Topics
Join the communities discussing this publication.